| 000 | 01725 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518090554.0 | ||
| 264 | 0 | _c20200616 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0229646 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEllis, Christopher R | |
| 245 | 0 | 0 |
_aEvaluating kratom alkaloids using PHASE. _h[electronic resource] |
| 260 |
_bPloS one _c2020 |
||
| 300 |
_ae0229646 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMitragyna _xchemistry |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aPlants, Medicinal _xchemistry |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 |
_aReceptors, Adrenergic _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
| 650 | 0 | 4 |
_aSecologanin Tryptamine Alkaloids _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aRacz, Rebecca | |
| 700 | 1 | _aKruhlak, Naomi L | |
| 700 | 1 | _aKim, Marlene T | |
| 700 | 1 | _aZakharov, Alexey V | |
| 700 | 1 | _aSouthall, Noel | |
| 700 | 1 | _aHawkins, Edward G | |
| 700 | 1 | _aBurkhart, Keith | |
| 700 | 1 | _aStrauss, David G | |
| 700 | 1 | _aStavitskaya, Lidiya | |
| 773 | 0 |
_tPloS one _gvol. 15 _gno. 3 _gp. e0229646 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0229646 _zAvailable from publisher's website |
| 999 |
_c30699699 _d30699699 |
||